DLL3 and urinary bladder small cell neuroendocrine carcinoma: Moreover, DLL3 was identified in a subset of small cell carcinomas of the bladder as a negative prognostic biomarker, and the in vivo efficacy of a DLL3-targeting conjugated antibody was demonstrated in a PDX model [29].